2024.04.05
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference
ROCKVILLE, MD, April 5, 2024 – I-Mab (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the 23rd Annual Needham Virtual Healthcare Conference on April 11, 2024. 23rd Annual Needham Virtual Healthcare Conference […]